α1-Antitrypsin and α1-antichymotrypsin are in the lesions of Alzheimerʼs disease
Article 1992 en
Authors
PG
Patricia A. Gollin
RK
Rajesh N. Kalaria
PE
Piet Eikelenboom
Abstract
1 min read
We performed immunocytochemistry to localize alpha 1-antichymotrypsin and alpha 1-antitrypsin in tissue sections of Alzheimer disease patients. Our results show that both serine protease inhibitors are localized in neurofibrillary tangles and senile plaques. Using various monoclonal and polyclonal antibodies, immunolabeling was evident in formalin, methacarn or acetone-fixed sections. Brief pretreatments of sections with either formic acid or guanidine-HCl were also necessary to reveal clear immunostaining of the lesions with two of the antibodies. We suggest that both alpha 1-antitrypsin and alpha 1-antichymotrypsin may be functionally involved in the pathogenesis of the lesions of Alzheimer's disease. Like alpha 1-antichymotrypsin, the major cell producing alpha 1-antitrypsin is likely to be astrocytes since the protein was localized there and astrocytes are involved in both lesions.
David Bonda, Maneesh Mailankot, Jeremy Stone, Matthew R. Garrett, Magdalena Staniszewska, Rudy J. Castellani, Sandra L. Siedlak, Xiongwei Zhu, Hyoung‐gon Lee, George Perry, Ram H. Nagaraj, Mark A. Smith
Mitsuru Kawai, Patrick Cras, Peggy L. Richey, Massimo Tabaton, David E. Lowery, Patricia A. Gonzalez‐DeWhitt, Barry Greenberg, Pierluigi Gambetti, George Perry
Justin Shenk, Rudy J. Castellani, Paula I. Moreira, Gjumrakch Aliev, Sandra L. Siedlak, Peggy L.R. Harris, Lawrence M. Sayre, Pamela A. Szweda, Mark A. Smith, George Perry
Discussion(0)
No comments yet. Be the first to comment.